Positive Trial Results Boost InterMune
Positive trial results for lung disease treatment pirfenidone boosted shares of InterMune Inc. (ITMN) $6.39 to close at $28.40.
posted by FC Market News at 1:49 PM
Friday, December 22, 2006
Previous Posts
- Positive Results For SciClone
- Pinnacle Settles With Northwest
- Cheniere Subsidiary Files For IPO
- Jabil Circuit Downgraded
- Onstream Media Launches Video Search
- GlaxoSmithKline Buys Praecis
- International Assets Swings To Loss
- Possible Partners For Accentia
- Psychicatric Solutions To Acquire Horizon Health
- No Casino License For Trump
0 Comments:
Post a Comment
<< Home